For digital health founders, a useful 2026 investor list starts with firms such as Define Ventures, Flare Capital Partners, 7wireVentures, and Rock Health Capital, then narrows by buyer, clinical risk, reimbursement, regulation, and stage. The 15 profiles below distinguish specialist healthcare experience from broad technology investing.
Digital health investors differ by buyer and risk model. Provider workflow, payer infrastructure, employer benefits, consumer care, diagnostics, devices, and value-based care require different sales networks, reimbursement knowledge, and clinical evidence. This list favors firms with an explicit healthcare mandate and recent sector activity.
There is no universal ranking. The best investor is the one whose current mandate, stage, geography, ownership model, and portfolio fit align with the company. Use this page as a researched starting point, then confirm current interest directly before sharing confidential information.
Finta research note: We evaluated healthcare specialists and technology firms with a sustained digital-health practice, then retained 15 investors with public evidence across buyer focus, stage, lead behavior, portfolio, and activity. Inclusion does not imply that a firm can invest in a company that competes with an existing portfolio business.
How we selected these investors
Research was last verified on August 8, 2026. We reviewed investor-controlled thesis, portfolio, team, fund, and transaction pages first. When an official source did not address a material field, we used reputable secondary reporting and labeled the claim accordingly. Inclusion required an explicit mandate or a repeat investment pattern, plus at least one current public signal. A well-known historical deal alone was not enough.
We assessed five factors:
- Sector fit, including the investor's stated thesis and the depth of relevant portfolio evidence.
- Stage fit, published check information, and documented lead or follow behavior.
- Current activity, based on recent investments, fund announcements, or a current investing mandate.
- Founder usefulness, including geographic reach, relevant operating support, and likely partner expertise.
- Evidence quality, with investor-controlled sources preferred over databases and press summaries.
Check sizes and lead behavior appear only when publicly supported. "Not publicly disclosed" means the current sources did not state the field, not that the firm lacks an internal range. We do not estimate remaining dry powder from assets under management, fund size, or a fund announcement. Portfolio examples show experience, not willingness to fund a similar or competing company.
This is a curated research list, not an exhaustive directory or a ranking from best to worst. Investor mandates, partner coverage, conflicts, and capacity can change after the research date. Confirm fit directly before sending confidential information or relying on a stated range.
Compare 15 healthtech and digital-health investors
| Investor | Verified stage | Public check size | Strongest fit | Lead or follow evidence | Recent signal |
|---|---|---|---|---|---|
| Define Ventures | Incubation, seed, Series A, and Series B | Not publicly disclosed | Digital health, healthcare AI, clinical workflow | Official source confirms lead activity | 2025: Participated in Hyro's $45 million growth round. |
| Flare Capital Partners | Early stage through growth; exact target stage range is not stated on the current site | Not publicly disclosed | Healthcare AI, digital health, payer and provider technology | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| 7wireVentures | Early stage | Not publicly disclosed | Consumer-centered digital health, virtual care, chronic-condition management | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| Rock Health Capital | Seed through growth based on the portfolio record; exact target stage is not stated on the current site | Not publicly disclosed | Digital health, virtual care, consumer health | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| HealthQuest Capital | Commercial and growth stage | Not publicly disclosed | Healthcare IT, tech-enabled services, medical devices | Official source confirms lead activity | 2025: Led OrganOx's $142 million equity financing. |
| Transformation Capital | Commercial-stage and growth-stage digital health | Not publicly disclosed | Digital health, virtual care, healthcare data | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| Oak HC/FT | Early stage through growth | Not publicly disclosed | Tech-enabled care, payer and provider software, healthcare AI | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| .406 Ventures | Seed and early venture stages | Not publicly disclosed | Healthcare technology, data and AI, clinical and administrative software | Official source confirms lead activity | 2024: Fund V announcement states four investments had already been made and targets more than 20 companies. |
| Maverick Ventures | Seed through Series B, with capacity to support companies from inception to IPO | Not publicly disclosed | Digital health, consumer health, care delivery | Official source confirms lead activity | Current mandate verified in 2026; recent deployment date not located |
| AlleyCorp Healthcare | Incubation, pre-seed, and seed | $1M to $4M entry investment | Tech-enabled care, specialty care, healthcare AI | Official source confirms lead activity | Current mandate verified in 2026; recent deployment date not located |
| Town Hall Ventures | All private-company stages | Not publicly disclosed | Care delivery, Medicaid and Medicare, rural health | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| Sante Ventures | Company formation and early stage | Not publicly disclosed | Healthcare technology, tech-enabled services, medical devices | Not publicly disclosed | 2026: Fund V announcement confirms new investment across biotechnology, medical technology, and digitally enabled healthcare. |
| Optum Ventures | Seed through growth; stage agnostic | Not publicly disclosed | Digital health, care delivery, payer and provider infrastructure | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| Echo Health Ventures | Venture and growth stages | Not publicly disclosed | Healthcare technology, payer and provider solutions, consumer health | Not publicly disclosed | Current mandate verified in 2026; recent deployment date not located |
| General Catalyst | Company creation and seed through growth | Not publicly disclosed | Digital health, healthcare AI, care delivery | Official source confirms lead activity | 2026: Led Yuzu's Series A. |
Why each healthtech investor may fit
Define Ventures
Define is purpose-built for early healthcare technology and reports more than $800M under management across incubation through Series B. Relevant portfolio examples are Fathom, Artera, Laudio.
Flare Capital Partners
Flare is a dedicated healthcare technology investor with a portfolio spanning healthcare data, clinical operations, and tech-enabled care. Relevant portfolio examples are Aetion, HealthVerity, Inbound Health.
7wireVentures
7wire is an early-stage digital health specialist with operator experience and a portfolio centered on technology-enabled healthcare consumers. Relevant portfolio examples are Livongo, Medisafe, 9am.health.
Rock Health Capital
Rock Health is a recognized digital health specialist with an established portfolio and current market research that strengthens its sector network. Relevant portfolio examples are Omada Health, Virta Health, Wheel.
HealthQuest Capital
HealthQuest is a strong fit for commercial-stage healthtech companies with demonstrated clinical or economic value and documented lead activity. Relevant portfolio examples are Inbound Health, OrganOx, Atropos Health.
Transformation Capital
Transformation is a dedicated digital health investor oriented toward companies that have moved beyond product formation into commercial scaling. Relevant portfolio examples are Sword Health, Datavant, Capital Rx.
Oak HC/FT
Oak HC/FT has a dedicated healthcare team, broad stage capacity, and an extensive portfolio in tech-enabled care and healthcare software. Relevant portfolio examples are Devoted Health, Quartet Health, Reveleer.
.406 Ventures
.406 is an established early-stage investor with a dedicated healthcare thesis, company-building support, and a $265M fifth fund closed in 2024. Relevant portfolio examples are Iora Health, AbleTo, Abacus Insights.
Maverick Ventures
Maverick publishes clear lead and stage behavior and has a strong portfolio across consumer health, care delivery, and insurance. Relevant portfolio examples are Hims & Hers, Cityblock Health, Devoted Health.
AlleyCorp Healthcare
AlleyCorp publishes a useful early-stage check range and is a strong fit for healthcare founders seeking hands-on company creation support. Relevant portfolio examples are Thyme Care, Pearl Health, Transcend Therapeutics.
Town Hall Ventures
Town Hall has a distinct mission and strong policy network for founders improving access and outcomes for underserved US populations. Relevant portfolio examples are Cityblock Health, Hopscotch Primary Care, Qualified Health.
Sante Ventures
Sante is a dedicated early-stage healthcare investor with current digital health and AI activity and a new Fund V announced in 2026. Relevant portfolio examples are Clairity, Reimagine Care, beHuman.
Optum Ventures
Optum Ventures offers broad stage coverage and strategic access to a major healthcare operating platform across care delivery and infrastructure. Relevant portfolio examples are DispatchHealth, Devoted Health, Unite Us.
Echo Health Ventures
Echo combines investment capital with strategic relationships across large health-plan partners and maintains current portfolio activity. Relevant portfolio examples are Springbuk, Eleanor Health, Genome Medical.
General Catalyst
General Catalyst has a dedicated Health Assurance strategy, broad stage capacity, and recent lead activity in healthcare infrastructure. Relevant portfolio examples are Oscar Health, Commure, Yuzu.
How to choose the right healthtech investor
Name the buyer, user, budget owner, and reimbursement path. Show how the product fits clinical workflow, procurement, privacy, security, and regulation. Pilots are not equal to recurring contracts, and booked lives are not equal to utilization. Care-delivery founders should explain clinical quality and medical cost. Health IT founders should quantify implementation, retention, and expansion.
Build a short list by scoring each investor on thesis, stage, geography, check compatibility, relevant partner, portfolio conflict, and ability to help with the next milestone. The operating proof most likely to matter in this category includes clinical outcomes, utilization, medical-cost impact, gross margin, renewal, implementation time, reimbursement, provider adoption, sales cycle, and regulatory readiness. Confirm who actually owns the thesis before requesting an introduction.
Round context matters. Compare this list with our investor pages for pre-seed, seed, Series A, Series B, and Series C. Geography can narrow the set further, including Boston investors and New York investors. For planning the process itself, use the pre-seed fundraising guide, seed fundraising guide, Series A fundraising guide, Series B fundraising guide, and Series C fundraising guide.
What to verify before outreach
Buyer access and clinical credibility are helpful only when the investor understands the company's exact reimbursement and regulatory exposure. Ask how it treats provider, payer, employer, and consumer conflicts, and whether strategic relationships come with commercial constraints. Clinical claims and patient-impact claims should be reviewed by qualified experts outside the fundraising process.
Frequently asked questions
How is digital health fundraising different from biotech fundraising?
Digital health is often underwritten around buyers, reimbursement, workflow, utilization, and software or care-delivery economics. Biotech financing is more often organized around scientific, regulatory, and clinical milestones.
How many investors should a founder contact?
Start with a qualified first wave, usually 20 to 40 firms. Run outreach in parallel, compare feedback, then expand from a researched reserve list. Fit and warm context usually matter more than raw volume.
What if an investor does not publish a check size?
Ask whether the raise and desired ownership fit the current strategy. Old database estimates and prior rounds can inform a question, but they are not verified current policy.
Do healthcare pilots count as traction?
A pilot is stronger when it is paid, implemented, used, and tied to a defined conversion or expansion decision. A large number of unpaid pilots can hide weak procurement and adoption.
Build a more precise investor list with Finta
Finta helps founders turn a broad market map into a ranked outreach workflow. Use your stage, sector, location, round size, traction, and network to identify higher-fit investors, prepare the raise, and manage follow-up. Build your investor target list with Finta.
Editorial review and disclosure
Reviewed by Kevin Siskar, CEO of Finta, an early-stage investor and founder-education operator. The Finta Editorial Team researched and edited this page using the sources listed below. Investor inclusion is an independent editorial decision and is not paid placement.
This article provides general fundraising information, not legal, tax, investment, or regulatory advice. Confirm a firm's current mandate, partner ownership, conflicts, and process directly before acting on the information.
Sources
- Define Ventures official source; additional official source; additional official source; fund source; recent activity source
- Flare Capital Partners official source; additional official source
- 7wireVentures official source; additional official source; additional official source
- Rock Health Capital official source; additional official source
- HealthQuest Capital official source; additional official source; additional official source
- Transformation Capital official source; additional official source; supporting source
- Oak HC/FT official source; additional official source; additional official source
- .406 Ventures official source; additional official source; additional official source
- Maverick Ventures official source; additional official source
- AlleyCorp Healthcare official source; additional official source
- Town Hall Ventures official source; additional official source; additional official source
- Sante Ventures official source; additional official source; additional official source; fund source
- Optum Ventures official source; additional official source
- Echo Health Ventures official source; additional official source; additional official source
- General Catalyst official source; additional official source; additional official source; fund source